Takatomo Yoneoka
Overview
Explore the profile of Takatomo Yoneoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
142
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takahashi F, Kano O, Nagano Y, Yoneoka T, Nelson S, Ushirogawa Y
Muscle Nerve
. 2022 Sep;
66(5):583-592.
PMID: 36054038
Introduction/aims: Edaravone in amyotrophic lateral sclerosis (ALS) was analyzed in two phase 3 studies (MCI186-16 and MCI186-19). Those trials enrolled patients with Japanese ALS severity grades 1 and 2 (less...
2.
Takahashi F, Kano O, Nagano Y, Yoneoka T, Nelson S, Ushirogawa Y
Muscle Nerve
. 2022 Sep;
66(5):593-602.
PMID: 36053970
Introduction/aims: In this study we examined the relationship between urate levels at baseline and functional change measured by the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) total score after edaravone...
3.
Abe K, Itoyama Y, Sobue G, Tsuji S, Aoki M, Doyu M, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2014 Oct;
15(7-8):610-7.
PMID: 25286015
Our objective was to confirm the efficacy and safety of edaravone in amyotrophic lateral sclerosis (ALS) patients. We conducted a 36-week confirmatory study, consisting of 12-week pre-observation period followed by...